Blood platelets and inflammation: Their relationship with liver and digestive diseases

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 5, 2011, Pages 353-357

  Ripoche, J ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND;

ENTERITIS; GASTROINTESTINAL DISEASE; HEMOSTASIS; HUMAN; INFLAMMATION; LIVER DISEASE; LIVER INJURY; LIVER REGENERATION; NONHUMAN; PATHOGENESIS; PLATELET MICROPARTICLE; SHORT SURVEY; THROMBOCYTE; THROMBOCYTE ACTIVATION; TISSUE REPAIR;

BLOOD PLATELETS; DIGESTIVE SYSTEM DISEASES; HUMANS; INFLAMMATION; LIVER DISEASES;

EID: 79956352570     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.02.012     Document Type: Short Survey

References (60)

1. Rendu F., Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets 2001, 12:261-273.
2. Bahou W.F., Gnatenko D.V. Platelet transcriptome: the application of microarray analysis to platelets. Semin Thromb Hemost 2004, 30:473-484.
3. Senzel L., Gnatenko D.V., Bahou W.F. The platelet proteome. Curr Opin Hematol 2009, 16:329-333.
4. Gnatenko D.V., Dunn J.J., McCorkle S.R., Weissmann D., Perrotta P.L., Bahou W.F. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003, 101:2285-2293.
5. Gnatenko D.V., Perrotta P.L., Bahou W.F. Proteomic approaches to dissect platelet function: half the story. Blood 2006, 108:3983-3991.
6. Blair P., Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009, 23:177-189.
7. Lindemann S., Tolley N.D., Dixon D.A., McIntyre T.M., Prescott S.M., Zimmerman G.A., et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1 beta synthesis. J Cell Biol 2001, 154:485-490.
8. Weyrich A.S., Lindemann S., Zimmerman G.A. The evolving role of platelets in inflammation. J Thromb Haemost 2003, 1:1897-1905.
9. Italiano J.E., Mairuhu A.T., Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 2010, 17:578-584.
10. Flaumenhaft R. Formation and fate of platelet microparticles. Blood Cells Mol Dis 2006, 36:182-187.
11. Mause S.F., Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010, 107:1047-1057.
12. Santos-Martinez M.J., Medina C., Jurasz P., Radomski M.W. Role of metalloproteinases in platelet function. Thromb Res 2008, 121:535-542.
13. Villeneuve J., Block A., Le Bousse-Kerdiles M.C., Lepreux S., Nurden P., Ripoche J., et al. Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organization for these secreted proteins. Exp Hematol 2009, 37:849-856.
14. Gawaz M., Langer H., May A.E. Platelets in inflammation and atherogenesis. J Clin Invest 2005, 115:3378-3384.
15. Schonbeck U., Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001, 58:4-43.
16. Czapiga M., Gao J.L., Kirk A., Lekstrom-Himes J. Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. Exp Hematol 2005, 33:73-84.
17. Del Conde I., Cruz M.A., Zhang H., Lopez J.A., Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J Exp Med 2005, 201:871-879.
18. Weyrich A.S., Zimmerman G.A. Platelets: signaling cells in the immune continuum. Trends Immunol 2004, 25:489-495.
19. May A.E., Seizer P., Gawaz M. Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol 2008, 28:s5-s10.
20. Smyth S.S., McEver R.P., Weyrich A.S., Morrell C.N., Hoffman M.R., Arepally G.M., et al. Platelet functions beyond hemostasis. J Thromb Haemost 2009, 7:1759-1766.
21. Boilard E., Nigrovic P.A., Larabee K., Watts G.F., Coblyn J.S., Weinblatt M.E., et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010, 327:580-583.
22. Markiewski M.M., DeAngelis R.A., Lambris J.D. Liver inflammation and regeneration: two distinct biological phenomena or parallel pathophysiologic processes?. Mol Immunol 2006, 43:45-56.
23. Lesurtel M., Graf R., Aleil B., Walther D.J., Tian Y., Jochum W., et al. Platelet-derived serotonin mediates liver regeneration. Science 2006, 312:104-107.
24. Nocito A., Georgiev P., Dahm F., Jochum W., Bader M., Graf R., et al. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology 2007, 45:369-376.
25. Myronovych A., Murata S., Chiba M., Matsuo R., Ikeda O., Watanabe M., et al. Role of platelets on liver regeneration after 90% hepatectomy in mice. J Hepatol 2008, 49:363-372.
26. Alkozai E.M., Nijsten M.W., de Jong K.P., de Boer M.T., Peeters P.M., Slooff M.J., et al. Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg 2010, 251:300-306.
27. McCaughan G.W., Herkes R., Powers B., Rickard K., Gallagher N.D., Thompson J.F., et al. Thrombocytopenia post liver transplantation. Correlations with preoperative platelet count, blood transfusion requirements, allograft function and outcome. J Hepatol 1992, 16:16-22.
28. Anitua E., Andia I., Ardanza B., Nurden P., Nurden A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004, 91:4-15.
29. Michalopoulos G.K. Liver regeneration. J Cell Physiol 2007, 213:286-300.
30. Martinez-Hernandez A., Amenta P.S. The extracellular matrix in hepatic regeneration. FASEB J 1995, 9:1401-1410.
31. Kim T.H., Mars W.M., Stolz D.B., Petersen B.E., Michalopoulos G.K. Extracellular matrix remodeling at the early stages of liver regeneration in the rat. Hepatology 1997, 26:896-904.
32. Iannacone M., Sitia G., Isogawa M., Marchese P., Castro M.G., Lowenstein P.R., et al. Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med 2005, 11:1167-1169.
33. Iannacone M., Sitia G., Narvaiza I., Ruggeri Z.M., Guidotti L.G. Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus. Clin Vaccine Immunol 2007, 14:1532-1535.
34. Lang P.A., Contaldo C., Georgiev P., El-Badry A.M., Recher M., Kurrer M., et al. Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med 2008, 14:756-761.
35. de Boer M.T., Christensen M.C., Asmussen M., van der Hilst C.S., Hendriks H.G., Slooff M.J., et al. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 2008, 106:32-44. [Table of contents].
36. Pereboom I.T., Lisman T., Porte R.J. Platelets in liver transplantation: friend or foe?. Liver Transpl 2008, 14:923-931.
37. Cywes R., Packham M.A., Tietze L., Sanabria J.R., Harvey P.R., Phillips M.J., et al. Role of platelets in hepatic allograft preservation injury in the rat. Hepatology 1993, 18:635-647.
38. Sindram D., Porte R.J., Hoffman M.R., Bentley R.C., Clavien P.A. Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver. Gastroenterology 2000, 118:183-191.
39. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669.
40. Bataller R., Brenner D.A. Liver fibrosis. J Clin Invest 2005, 115:209-218.
41. Gressner A.M., Bachem M.G. Cellular sources of non collagenous matrix proteins: role of fat-storing cells in fibrogenesis. Semin Liver Dis 1990, 10:30-46.
42. Hernandez-Gea V., Friedman S.L. Pathogenesis of liver fibrosis. Annu Rev Pathol 2011, 6:425-456.
43. Hernandez-Gea V, Friedman SL. Platelets arrive at the scene of fibrosis studies. J Hepatol 2010 [Epub ahead of print].
44. Zaldivar M.M., Pauels K., von Hundelshausen P., Berres M.L., Schmitz P., Bornemann J., et al. CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis. Hepatology 2010, 51:1345-1353.
45. Assy N., Hussein O., Khalil A., Luder A., Szvalb S., Paizi M., et al. The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis. Dig Dis Sci 2007, 52:1187-1193.
46. Mason K.D., Carpinelli M.R., Fletcher J.I., Collinge J.E., Hilton A.A., Ellis S., et al. Programmed anuclear cell death delimits platelet life span. Cell 2007, 128:1173-1186.
47. Kodama T., Takehara T., Hikita H., Shimizu S., Li W., Miyagi T., et al. Thrombocytopenia exacerbates cholestasis-induced liver fibrosis in mice. Gastroenterology 2010, 138:2487-2498. [98e1-7].
48. Watanabe M., Murata S., Hashimoto I., Nakano Y., Ikeda O., Aoyagi Y., et al. Platelets contribute to the reduction of liver fibrosis in mice. J Gastroenterol Hepatol 2009, 24:78-89.
49. Grozovsky R., Hoffmeister K.M., Falet H. Novel clearance mechanisms of platelets. Curr Opin Hematol 2010, 17:585-589.
50. Zhang H., Nimmer P.M., Tahir S.K., Chen J., Fryer R.M., Hahn K.R., et al. Bcl-2 family proteins are essential for platelet survival. Cell Death Differ 2007, 14:943-951.
51. Danese S., de la Motte C., Sturm A., Vogel J.D., West G.A., Strong S.A., et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003, 124:1249-1264.
52. Vogel J.D., West G.A., Danese S., De La Motte C., Phillips M.H., Strong S.A., et al. CD40-mediated immune-non immune cell interactions induce mucosal fibroblast chemokines leading to T-cell transmigration. Gastroenterology 2004, 126:63-80.
53. Vowinkel T., Anthoni C., Wood K.C., Stokes K.Y., Russell J., Gray L., et al. CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon. Gastroenterology 2007, 132:955-965.
54. Viallard J.F., Solanilla A., Gauthier B., Contin C., Dechanet J., Grosset C., et al. Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood 2002, 99:2612-2614.
55. Sprague D.L., Sowa J.M., Elzey B.D., Ratliff T.L. The role of platelet CD154 in the modulation in adaptive immunity. Immunol Res 2007, 39:185-193.
56. Villeneuve J., Lepreux S., Mulot A., Berard A.M., Higa-Nishiyama A., Costet P., et al. A protective role for CD154 in hepatic steatosis in mice. Hepatology 2010, 52:1968-1979.
57. Gay L.J., Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer 2011, 11:123-134.
58. Ferroni P., Spila A., D'Alessandro R., Martini F., Iacovone F., Ettorre G.M., et al. Platelet activation and vascular endothelial growth factor 165 release in hepatocellular cancer. Clin Chim Acta 2011, 412:450-454.
59. Verheul H.M., Hoekman K., Luykx-de Bakker S., Eekman C.A., Folman C.C., Broxterman H.J., et al. Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 1997, 3:2187-2190.
60. Solanilla A., Villeneuve J., Auguste P., Hugues M., Alioum A., Lepreux S., et al. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis. Rheumatology (Oxford) 2009, 48:1036-1044.